Evidence map›Paper›PMID 41515906›Full record

ArticleInternational journal of molecular sciences2025

Neuroinflammatory and Redox Responses in a Rat Model of NTG-Induced Migraine.

Anastasia A Kochneva, Aleksey N Ikrin, Natalia O Fokeeva, Olga V Yakovleva, Ksenia S Bogatova, Aleksey V Yakovlev, Elena Yu Radomskaya, Margarita A Khlystova, Veronika A Katrukha, Kristina V Vasilyeva and 9 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Anastasia A KochnevaDepartment of Neurobiology, Scientific Center of Genetics and Life Sciences, Sirius University of Science and Technology, Federal Territory of Sirius, 354340 Sochi, Russia.
Aleksey N IkrinDepartment of Neurobiology, Scientific Center of Genetics and Life Sciences, Sirius University of Science and Technology, Federal Territory of Sirius, 354340 Sochi, Russia.
Natalia O FokeevaDepartment of Neurobiology, Scientific Center of Genetics and Life Sciences, Sirius University of Science and Technology, Federal Territory of Sirius, 354340 Sochi, Russia.ORCID 0009-0008-2399-3742
Olga V YakovlevaDepartment of Human and Animal Physiology, Institute of Fundamental Medicine and Biology, Kazan Federal University, 420012 Kazan, Russia.
Ksenia S BogatovaDepartment of Human and Animal Physiology, Institute of Fundamental Medicine and Biology, Kazan Federal University, 420012 Kazan, Russia.
Aleksey V YakovlevDepartment of Human and Animal Physiology, Institute of Fundamental Medicine and Biology, Kazan Federal University, 420012 Kazan, Russia.ORCID 0000-0003-1112-1329
Elena Yu RadomskayaDepartment of Neurobiology, Scientific Center of Genetics and Life Sciences, Sirius University of Science and Technology, Federal Territory of Sirius, 354340 Sochi, Russia.
Margarita A KhlystovaM.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.ORCID 0009-0002-3802-4684
Veronika A KatrukhaM.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.ORCID 0000-0003-3228-2068
Kristina V VasilyevaM.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
Andrei M KarhovM.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.ORCID 0000-0003-0919-0712
Maxim A SolotenkovLife Improvement by Future Technologies Center, 121205 Moscow, Russia.
Aleksandr A MoshchenkoFederal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, 117513 Moscow, Russia.ORCID 0000-0003-4833-4686
Vsevolod V BelousovM.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.ORCID 0000-0001-6637-8098
Ilya V FedotovLife Improvement by Future Technologies Center, 121205 Moscow, Russia.
Pavel E MusienkoDepartment of Neurobiology, Scientific Center of Genetics and Life Sciences, Sirius University of Science and Technology, Federal Territory of Sirius, 354340 Sochi, Russia.
Guzel F SitdikovaDepartment of Neurobiology, Scientific Center of Genetics and Life Sciences, Sirius University of Science and Technology, Federal Territory of Sirius, 354340 Sochi, Russia.ORCID 0000-0001-5412-2204
Dmitry S BilanM.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.ORCID 0000-0002-4166-356X
Elena V GerasimovaDepartment of Neurobiology, Scientific Center of Genetics and Life Sciences, Sirius University of Science and Technology, Federal Territory of Sirius, 354340 Sochi, Russia.ORCID 0000-0002-0623-8496

Funding

Russian Science Foundation 23-15-00328Russian Science Foundation 25-15-00548
6 · The paper itself

Abstract

Neuroinflammation is a common pathophysiological feature of many disorders affecting the central nervous system, including migraine-one of the most prevalent neurological conditions, which significantly impairs quality of life, particularly when it progresses to the chronic form. The aim of the present study was to analyze oxidative changes following a single administration of nitroglycerin (NTG), as well as to investigate alterations in the glial microenvironment and inflammatory processes induced by chronic NTG administration. Registration of biosensor signals (HyPer7 and SypHer3s) in vivo did not reveal changes in hydrogen peroxide levels or pH following single NTG administration in striatum and cortex. In contrast, analysis of chronic NTG administration indicates neuroinflammatory processes occurring in the thalamus and the dentate gyrus of the hippocampus, but not in the somatosensory cortex without disruption of the BBB and decreased degranulation of meningeal mast cells. We observed a decrease in the mRNA expression in the thalamic tissue of the neuroprotective transforming growth factor beta 1 gene and an increase in the expression of the pro-inflammatory interferon gamma. The regional specificity of neuroinflammation supports the suggestion that maladaptive changes in these structures could play a critical role in the transition from episodic to chronic migraine.

Indexed as

Migraine DisordersNeuroinflammatory DiseasesNitroglycerinAnimalsDisease Models, AnimalHydrogen PeroxideMaleMast CellsOxidation-ReductionRatsTransforming Growth Factor beta1Hydrogen PeroxideNitroglycerinTransforming Growth Factor beta1fiber-optic interface technologyhydrogen peroxideHyPer7migraineneuroinflammationnitroglycerinepHSypHer3s

Identifiers

PMID41515906
PMCPMC12785633

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.